These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 26431249)
21. The pharmacokinetics and pharmacodynamics of rapid-acting insulin analogues and their clinical consequences. Home PD Diabetes Obes Metab; 2012 Sep; 14(9):780-8. PubMed ID: 22321739 [TBL] [Abstract][Full Text] [Related]
22. Diabetes, cancer and treatment - a mini-review. Vestergaard P; Starup-Linde J Curr Drug Saf; 2013 Nov; 8(5):292-5. PubMed ID: 24215309 [TBL] [Abstract][Full Text] [Related]
23. Treatment with the long-acting insulin analogues detemir or glargine during pregnancy in women with type 1 diabetes: comparison of glycaemic control and pregnancy outcome. Callesen NF; Damm J; Mathiesen JM; Ringholm L; Damm P; Mathiesen ER J Matern Fetal Neonatal Med; 2013 Apr; 26(6):588-92. PubMed ID: 23211128 [TBL] [Abstract][Full Text] [Related]
24. Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir. Peterson GE Curr Med Res Opin; 2006 Dec; 22(12):2613-9. PubMed ID: 17166343 [TBL] [Abstract][Full Text] [Related]
25. Controversies in the use of insulin analogues. Werner H; Weinstein D; Yehezkel E; Laron Z Expert Opin Biol Ther; 2011 Feb; 11(2):199-209. PubMed ID: 21219237 [TBL] [Abstract][Full Text] [Related]
26. Pharmacotherapy for hyperglycemia in pregnancy - The new insulins. Toledano Y; Hadar E; Hod M Diabetes Res Clin Pract; 2018 Nov; 145():59-66. PubMed ID: 29730391 [TBL] [Abstract][Full Text] [Related]
28. Insulin analogues: an example of applied medical science. Sheldon B; Russell-Jones D; Wright J Diabetes Obes Metab; 2009 Jan; 11(1):5-19. PubMed ID: 19120431 [TBL] [Abstract][Full Text] [Related]
29. Design and rationale of a large, international, prospective cohort study to evaluate the occurrence of malformations and perinatal/neonatal death using insulin detemir in pregnant women with diabetes in comparison with other long-acting insulins. Mathiesen ER; Andersen H; Kring SI; Damm P BMC Pregnancy Childbirth; 2017 Jan; 17(1):38. PubMed ID: 28100192 [TBL] [Abstract][Full Text] [Related]
30. Randomized controlled trial of insulin detemir versus NPH for the treatment of pregnant women with diabetes. Herrera KM; Rosenn BM; Foroutan J; Bimson BE; Al Ibraheemi Z; Moshier EL; Brustman LE Am J Obstet Gynecol; 2015 Sep; 213(3):426.e1-7. PubMed ID: 26070699 [TBL] [Abstract][Full Text] [Related]
31. Insulin analogs and pregnancy: an update. Torlone E; Di Cianni G; Mannino D; Lapolla A Acta Diabetol; 2009 Sep; 46(3):163-72. PubMed ID: 19572099 [TBL] [Abstract][Full Text] [Related]
32. Insulin analogues - state of the art. Standl E Horm Res; 2002; 57 Suppl 1():40-5. PubMed ID: 11979021 [TBL] [Abstract][Full Text] [Related]
33. Is the use of insulin lispro safe in pregnancy? Buchbinder A; Miodovnik M; Khoury J; Sibai BM J Matern Fetal Neonatal Med; 2002 Apr; 11(4):232-7. PubMed ID: 12375676 [TBL] [Abstract][Full Text] [Related]
34. Perinatal outcomes associated with the use of glargine during pregnancy. Di Cianni G; Torlone E; Lencioni C; Bonomo M; Di Benedetto A; Napoli A; Vitacolonna E; Mannino D; Lapolla A; ; Diabet Med; 2008 Aug; 25(8):993-6. PubMed ID: 18959615 [TBL] [Abstract][Full Text] [Related]
35. Refining basal insulin therapy: what have we learned in the age of analogues? Devries JH; Nattrass M; Pieber TR Diabetes Metab Res Rev; 2007 Sep; 23(6):441-54. PubMed ID: 17668418 [TBL] [Abstract][Full Text] [Related]
36. New insulins in the treatment of diabetes mellitus. Lindholm A Best Pract Res Clin Gastroenterol; 2002 Jun; 16(3):475-92. PubMed ID: 12079270 [TBL] [Abstract][Full Text] [Related]
37. Cross-reactivity of insulin analogues with three insulin assays. Dayaldasani A; Rodríguez Espinosa M; Ocón Sánchez P; Pérez Valero V Ann Clin Biochem; 2015 May; 52(Pt 3):312-8. PubMed ID: 25172526 [TBL] [Abstract][Full Text] [Related]
38. Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes. Klein O; Lynge J; Endahl L; Damholt B; Nosek L; Heise T Diabetes Obes Metab; 2007 May; 9(3):290-9. PubMed ID: 17391154 [TBL] [Abstract][Full Text] [Related]
39. New strategies in insulin treatment: analogues and noninvasive routes of administration. Rungby J; Brock B; Schmitz O Fundam Clin Pharmacol; 2005 Apr; 19(2):127-32. PubMed ID: 15810892 [TBL] [Abstract][Full Text] [Related]